Assessment of the Effect of an Implant System With a Novel Abutment Attachment Design on Crestal Bone Preservation
- Conditions
- Partial EdentulismTooth Disease
- Interventions
- Device: Nanotite Certain Tapered implantDevice: New Abutment Connection implant
- Registration Number
- NCT01529879
- Lead Sponsor
- ZimVie
- Brief Summary
Integration success rates and the preservation of crestal bone will be higher for the experimental device than for the control implants.
- Detailed Description
In this study patients are randomized to receive either the experimental implant system or the control Nanotite Certain Tapered (standard abutment connection) and assessed for integration success measured by lack of implant mobility and lack of bone loss obtained at various study time points
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 49
- patients of either sex and older than 18 years of age
- patients needing at least one dental implant to treat partial edentulism
- patients physically able to tolerate surgical and restorative dental procedures
- patients agreeing to all protocol visits
- patients with infection or severe inflammation at the intended treatment sites
- patients smoking greater than 10 cigarettes per day
- patients with uncontrolled diabetes mellitus
- patients with uncontrolled metabolic diseases
- patients who received radiation treatment to the head in the past 12 months
- patients needing bone grafting at the intended treatment sites
- patients known to be pregnant at screening visit
- patients with para-functional habits like bruxing and clenching
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Nanotite Certain Tapered implant Nanotite Certain Tapered implant Nanotite Certain Tapered (standard abutment connection) implant New abutment connection implant New Abutment Connection implant Implant with new abutment connection
- Primary Outcome Measures
Name Time Method Cumulative success rate 2 years Crestal bone regression (amount of bone loss measured) and equivalence in integration success (implant mobility)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UNICOC
🇨🇴Bogota, Colombia